Association between clinical parameters and disease-free survival.

Figshare2015-12-02 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/_Association_between_clinical_parameters_and_disease_free_survival_/394325 数据链接链接失效反馈

官方服务：

资源简介：

Association between clinical parameters and disease-free survival.

创建时间：

2015-12-02

An observational study of apatinib combined with XELOX regimen in postoperative adjuvant therapy of colorectal cancer

结直肠癌辅助化疗

抗肿瘤药物疗效评估

Interventions: experimental group:Apatinib combined with oxaliplatin and capecitabine (XELOX) g Primary outcome(s): Disease free survival Study Design: Single arm

NIAID Data Ecosystem80

Compendium subtype distribution.

疾病亚型分类

临床预后分析

Distribution of class labels and subtypes for the 892 samples with a proper class label. and denote the number of negative (good prognosis) and positive (poor prognosis) cases of for each subtype ,

NIAID Data Ecosystem20

Median overall survival and progression-free survival hazard ratios (HRs) and 95% Credible Intervals for cabazitaxel, abiraterone and enzalutamide using Bayesian fixed effects modeling.

抗肿瘤药物疗效评估

贝叶斯生存分析

Median overall survival and progression-free survival hazard ratios (HRs) and 95% Credible Intervals for cabazitaxel, abiraterone and enzalutamide using Bayesian fixed effects modeling.

NIAID Data Ecosystem20

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)

转移性结直肠癌维持与支持治疗

抗肿瘤药物疗效评估

PURPOSE: This randomized phase III trial is studying maintenance therapy with bevacizumab alone after an induction therapy combining bevacizumab+chemotherapy to see how well they work compared to main

NIAID Data Ecosystem40

Adjusted hazard ratios for the risk of PTA recurrence.

咽旁脓肿复发风险

临床预后分析

Abbreviations: aHR, adjusted hazard ratio; CI, confidence interval.Adjusted hazard ratios for the risk of PTA recurrence.

Figshare2015-12-02 更新20